Results from the Phase III EPCORE FL-1 trial (NCT05409066) showed that patients treated with Epkinly (epcoritamab) in combination with Rituxan (rituximab) and Revlimid (lenalidomide) for relapsed or ...

We also continue to watch Adriatic Metals Vareš mine, which achieved commercial production on July 1, 2025, roughly in line with the operator's target of Q2 2025. On July 28, Adriatic Metals reduced ...

Background Racial and ethnic disparities in infectious disease burden have been reported in the USA and globally, most recently during the COVID-19 pandemic. It remains unclear whether such ...

The Trump administration on Friday ordered a comprehensive review of Harvard University's federally funded research programs, ...

The promising results, along with a separate FDA decision, could signal a major expansion of the use of the two companies' ...

The Quantum Frederick data center campus is one of six projects selected as part of a pilot program to expedite Maryland’s permitting review process, the office of Gov. Wes Moore announced on Tuesday.

Epkinly with Rituxan and Revlimid, compared to Rituxan and Revlimid alone, reduced risk of progression or death by 79%.

Epcoritamab shows promising results in treating relapsed follicular lymphoma, with FDA priority review for a groundbreaking ...

Stockbridge — For Berkshire newcomers straying into the candidate’s forum on Wednesday, Aug. 6, confusion must have set in as ...

Treatments for acromegaly, edema, HSCT-associated thrombotic microangiopathy, multiple sclerosis, and spinal muscular atrophy are under review.

The Town Board agreed Tuesday to scrap a companion statement to the New York State “Pro-Housing Community” agreement that had ...